Skip to content

ANNX

Annexon, Inc.

NASDAQ · USHealthcareBiotechnology
$5.80-1.53%

Price as of Jul 17, 2026

ANNX earnings

Annexon, Inc. earnings

Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.

Next earnings
Aug 13, 2026in NaN days
EPS est $-0.23 · Revenue est $7M
Track record
Beat EPS in 7 of 12 quarters
Avg surprise +5.9% (last 4 quarters)
Earnings history
Report dateEPS estEPS actualSurpriseRevenueRev. surprise
May 7, 2026$-0.30$-0.23+23.3%
Mar 30, 2026$-0.32$-0.28+12.5%
Aug 14, 2025$-0.36$-0.34+5.6%
Mar 3, 2025$-0.28$-0.33-17.9%
Nov 14, 2024$-0.26$-0.25+3.8%
Nov 13, 2023$-0.50$-0.43+14.0%
Mar 6, 2023$-0.52$-0.48+7.7%
Nov 3, 2022$-0.87$-0.51+41.4%
Mar 1, 2022$-0.90$-0.97-7.8%
Aug 16, 2021$-0.68$-0.82-20.6%
May 17, 2021$-0.60$-0.68-13.3%
Mar 25, 2021$-0.42$-0.61-45.2%

Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-13.